<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Exp. Biol. Med.</journal-id>
<journal-title-group>
<journal-title>Experimental Biology and Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Exp. Biol. Med.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1535-3699</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">10958</article-id>
<article-id pub-id-type="doi">10.3389/ebm.2026.10958</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Correction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Correction: Protective effects of berberine-loaded chitosan/solid lipid nanoparticles in streptozotocin-induced gestational diabetes mellitus rats</article-title>
<alt-title alt-title-type="left-running-head">EBM Production Office</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/ebm.2026.10958">10.3389/ebm.2026.10958</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>EBM Production Office</collab>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label/>
<institution>Frontiers Media SA</institution>, <city>Lausanne</city>, <country country="CN">Switzerland</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: EBM Production Office, <email xlink:href="mailto:production@ebm-journal.org">production@ebm-journal.org</email>, </corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-08-03">
<day>03</day>
<month>08</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>251</volume>
<elocation-id>10958</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>26</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 EBM Production Office.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>EBM Production Office</copyright-holder>
<license>
<ali:license_ref start_date="2026-08-03">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Exp. Biol. Med." journal-id-type="nlm-ta" xlink:href="10.3389/ebm.2025.10749" ext-link-type="doi">A Correction on <article-title>Protective effects of berberine-loaded chitosan/solid lipid nanoparticles in streptozotocin-induced gestational diabetes mellitus rats</article-title> by Liu Y, Hussain SA and Yue H (2025). Exp. Biol. Med. 250:10749. doi: <object-id>10.3389/ebm.2025.10749</object-id>
</related-article>
<kwd-group>
<kwd>berberine</kwd>
<kwd>chitosan</kwd>
<kwd>gestational diabetes mellitus</kwd>
<kwd>rat</kwd>
<kwd>solid lipid nanoparticle</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="1"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Pharmacology and Toxicology</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p>In the main article, the name of the ethics committee was erroneously given as &#x201c;the Institutional Ethics Committee and Research Advisory Committee of the King Saud University, Saudi Arabia&#x201d; and the location that the rats were obtained from was erroneously given as &#x201c;the laboratory animal research center of the College of Science, King Saud University, Saudi Arabia&#x201d;.</p>
<p>A correction has been made to the <bold>Material and Methods section,</bold> subsection &#x2018;Gestational rats&#x2019;. The correct paragraph appears below:</p>
<p>&#x201c;Forty-nine female (180 &#xb1; 10&#xa0;g) and seven male (230 &#xb1; 10&#xa0;g) Wistar-Albino rats (8&#x2013;10&#xa0;weeks old) were obtained from Takassusi BioMedical, Riyadh, Saudi Arabia. All animal experiments were performed in full accordance with the Animal Welfare instructions and approved by Zhinanzhen Biology Ethics Committee, [No.: A2025000127.]&#x201d;</p>
<p>The original version of this article has been updated.</p>
</body>
</article>